Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Blackstone and TPG-backed Hologic agrees deal for precision oncology firm Reveal Genomics

Barcelona-based Reveal Genomics develops genomic diagnostic tests to guide cancer treatment, including HER2DX for HER2-positive breast cancer. The post Blackstone and TPG-backed Hologic agrees deal for precision oncology firm Reveal Genomics appeared first on PE Hub .

We haven't written up this one. PE Hub has the full story — the link below goes straight to it.

Read the original at pehub.com →

More in Finance & Markets

Wall Street Lowers Netflix Stock Price Targets After Weak Outlook Overshadows Q3 Earnings

Shares of the streamer extended their losses another 4% on Wednesday The post Wall Street Lowers Netflix Stock Price Targets After Weak Outlook Overshadows Q3 Earnings appeared first on TheWrap .

  • Wall Street analysts lowered Netflix stock price targets after weaker Q3 earnings guidance.
  • Netflix projected slower fourth-quarter revenue growth and lower ad sales for 2026.
  • Analysts cited concerns about engagement growth and focus on too many distractions.

More from Wednesday 21 October →